FeesSafety
Pluang+

Talamore Mining upgrades to OTCQX, boosting U.S. investor access for its Yukon gold project.

Market News
10 Nov 2026, 14:00 WIB
GlobeNewsWire
View Source
Bullish
Talamore Mining upgrades to OTCQX, boosting U.S. investor access for its Yukon gold project.

Talamore Mining Corp., a Canadian mineral exploration company, has upgraded its trading to the OTCQX Best Market from the OTCQB Venture Market, enhancing its visibility and accessibility to U.S. investors. The company is advancing the Coffee Gold Project in Yukon, Canada, which is nearing final permitting and engineering stages, with a construction decision forthcoming. Talamore also holds copper and gold assets in Chile and Mexico, offering long-term growth potential. This move reflects the company's progress and aims to broaden its investor base in the U.S. market.

Talamore Mining Corp.'s trading upgrade is noted alongside Pluang's Basic Materials sector data as of Nov 10, 2026 18:41 WIB. For readers following Basic Materials, here is Pluang's market snapshot: out of 83 priced US stocks, 26 rose and 54 fell today. Notable movers include Endeavour Silver Corp (EXK) at USD 8.00 with a -4.08% change and 99% sell order activity, AngloGold Ashanti Limited (AU) at USD 95.90 with a -3.49% change and 98% sell order activity, and Aura Minerals Inc. (AUGO) at USD 84.01 with a -3.43% change. The most notable figure is the 99% sell order activity for EXK.

More News

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...

Market News
Neutral
59 minutes ago
Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...

Market News
Bullish
59 minutes ago
PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...

Company Fundamentals
Bullish
59 minutes ago
Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...

Company Fundamentals
Bullish
59 minutes ago
Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App